FDA Acceptance of Foreign Clinical Studies Not Conducted Under an IND: Frequently Asked Questions: Guidance for Industry and FDA Staff
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 1, 2012
February 3, 2025
5708effd-f435-4af2-bdba-f8d7590073d4
Related Documents
Considerations When Transferring Clinical Investigation Oversight to Another IRB: Guidance for IRBs, Clinical Investigators, and Sponsors
Guidance DocumentMay 23, 2014Office of the Commissioner
E7 Studies in Support of Special Populations; Geriatrics; Questions and Answers
Guidance DocumentMarch 1, 2012Center for Drug Evaluation and Research
IRB Continuing Review After Clinical Investigation Approval: Guidance for IRBs, Clinical Investigators, and Sponsors
Guidance DocumentFebruary 27, 2012Office of the Commissioner
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox